34 reports

EXECUTIVE SUMMARY ##.

  • Liver Cancer
  • APAC
  • World
  • Market Shares
  • Liver Cancer Overview
  • III. LIVER CANCER TREATMENT DRUGS

The liver cancer treatment drugs industry is one of key sectors of Chinese industry and has become more and more important.

  • Liver Cancer
  • China
  • Demand
  • Novartis AG
  • Sanofi-Synthelabo Inc.
  • Liver Cancer Treatment Drugs Companies in China
  • Liver Cancer Treatment Drugs Sales Volume

The liver cancer treatment drugs industry is one of key sectors of Chinese industry and has become more and more important.

  • Liver Cancer
  • China
  • Biostar Pharmaceuticals, Inc.
  • Novartis AG
  • Sanofi-Synthelabo Inc.
  • Liver Cancer Overview
  • IV. LIVER CANCER TREATMENT DRUGS PRODUCTION AND

INTRODUCTION Chapter I Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) Chapter I INTRODUCTION The current market for liver cancer treatment drugs in China is growing rapidly.

  • Liver Cancer
  • China
  • Demand
  • Trade
  • Hainan Haiyao Company Limited

Liver Cancer Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Diagnostics
  • Liver Cancer
  • APAC
  • World
  • Market Size

Liver Cancer Diagnostic Market Size, Share & Trends Analysis Report By Screening Type, By Region And Segment Forecasts, 2019 - 2025 Chapter ## Methodology and Scope ##. ## Research Methodology ##. ##. ## Information Procurement ##. ## Information or Data Analysis ##. ## Research Scope and Ass

  • Cancer
  • Liver Cancer
  • North America
  • United States
  • Market Size

Liver Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class, By Country And Segment Forecasts, 2016 - 2022 Chapter ## Research Methodology ##. ##.

  • Cancer
  • Liver Cancer
  • United Kingdom
  • United States
  • Forecast
  • FEATURES OF LIVER CANCER PATIENTS
  • Incidence of Liver Cancer, females (000s)

HPB. 2005; ##(##):##-##. ##.

  • Cancer
  • Hepatitis
  • Liver Cancer
  • Pathology

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Liver Cancer
  • France
  • United States
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Liver Cancer
  • France
  • Germany
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • Japan
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • United States
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • United Kingdom
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • Italy
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • Germany
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • France
  • Market Shares
  • Market Size

Hepatoma Liver Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Liver Cancer
  • Spain
  • Market Shares
  • Market Size
  • Liver Cancer Diagnostic Tests Companies and Product
  • Liver Cancer Diagnostic Tests - Pipeline Products under Development by

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019 H e a l t h c a r e H e a l t h c a r e Report Code: Published: GDME##EPD November 2019 ## ## ## ## ## ## ## ## Ymir Genomics LLC.

  • Cancer
  • Clinical Trial
  • Hepatitis
  • Liver Cancer
  • Pfizer Inc.

Metastatic Liver Cancer - Pipeline Insight, 2020 ##.

  • Cancer
  • Liver Cancer
  • Therapy

The report focuses on drugs and therapies being evaluated for Metastatic Liver Cancer treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Cancer
  • Clinical Trial
  • Drug Development
  • Liver Cancer
  • Pathology
  • 7.5 United States - Liquid Biopsy Liver Cancer Treatment Monitoring
  • 6.5 United States - Liquid Biopsy Liver Cancer Screening Potential

Liver Cancer The Top ## Cancer Segments covered are: ##.

  • Liver Cancer
  • North America
  • United States
  • Forecast
  • Biocept, Inc.
  • 4.4.1 United States - Liver Cancer Biopsy Test Market & Forecast
  • 4.4 United States - Liver Cancer Biopsy Test Market & Volume

Surgical Biopsy ##.

  • Biopsy
  • Liver Cancer
  • Prostate Cancer
  • United States
  • Forecast
  • Symptoms of Liver Cancer
  • Liver Cancer, Molecular Target Category

A poor quality diet, particularly one characterized by high alcohol consumption, is another significant risk factor in liver cancer.

  • Cancer
  • Hepatitis
  • Liver Cancer
  • Pathology
  • Therapy
  • JUN 19, 2018: CAN-FITE UPDATES ON STATUS OF PHASE II ADVANCED LIVER CANCER TRIAL
  • NOV 04, 2019: CAN-FITE INITIATES COMPASSIONATE USE PROGRAM FOR NAMODENOSON IN THE TREATMENT OF LIVER CANCER, ENROLLS AND TREATS PATIENTS

Fishman is scheduled to conduct one-on-one meetings with potential commercialization and out-licensing partners.

  • Autoimmune Disease
  • Liver Cancer
  • United States
  • Product Initiative
  • Can-Fite BioPharma Ltd.

Liver cancer Pipeline Highlights – 2017 ##.

  • Cancer
  • Liver Cancer
  • United States
  • Product Initiative

Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Phase ##, Preclinical and Discovery stages comprises ##, ##, ##, ##, ## and ## molecules, respectively.

  • Cancer
  • Liver Cancer
  • Pathology
  • Pharmaceutical
  • Therapy

Liver Cancer - Pipeline Review, H## 2016 Table of Contents Table of Contents ## Introduction ## Liver Cancer Overview ## Therapeutics Development ## Liver Cancer - Therapeutics under Development by Companies ## Liver Cancer - Therapeutics under Investigation by Unive

  • Cancer
  • Liver Cancer
  • Pathology
  • Pharmaceutical
  • Therapy
  • NBTXR3 - LIVER CANCER
  • NBTXR3 - LIVER CANCER PRODUCT OVERVIEW

## Liver Cancer ## Lung Cancer ## Pancreatic Cancer ## Prostate Cancer ## Rectal Diseases ## Soft Tissue Cancer ## Nanobiotix SA Ongoing Clinical Trials by Trial Status Ongoing, Recruiting ## Planned ## Ongoing, not Recruiting

  • Liver Cancer
  • Neck Cancer
  • United States
  • Product Initiative
  • Nanobiotix
  • Clinical Trial profile. 65 Trial Title
  • Clinical Trial profile. 78 Trial Title

Bonafede / PosterDate/ Time (EDT): Oct. ##, 2017, ##:## - ##:## p. m. Location/ Session: Clinical Liver Cancer, Hall D About OpdivoOpdivo is a programmed death-## (PD-##) immune checkpoint inhibitor that is designed to uniquely harness the body' s own immune sy

  • Hepatitis
  • Hospital
  • Liver Cancer
  • World
  • Product Initiative
  • SURVIVIN-IGM KIT - LIVER CANCER
  • COMPLEXIMA HCC BIOCHIP - LIVER CANCER

Liver Cancer ## Breast Cancer ## Colorectal Cancer ## Esophageal Cancer ## Cervical Cancer ## Lung Cancer ## Non-Alcoholic Steato-Hepatitis (NASH) ## Prostate Cancer ## Scleroderma ## Indication No of Products XEPTAGEN SPA - PIPELINE ANALYSIS OVE

  • Bioinformatics
  • Cancer
  • In Vitro Diagnostics
  • Liver Cancer